Long-term retention in Office Based Opioid Treatment with buprenorphine

详细信息    查看全文

• 作者：Zoe M. Weinstein^a ; ^{zoe.weinstein@bmc.org} ; Hyunjoong W. Kim^b ; Debbie M. Cheng^c ; Emily Quinn^d ; David Hui^b ; Colleen T. Labelle^a ; Mari-Lynn Drainoni^e ; ^f ; ^g ; Sara S. Bachman^e ; ^h ; Jeffrey H. Samet^a ; ⁱ
• 关键词：Buprenorphine ; Office Based Opioid Treatment (OBOT) ; Substance users ; Patient dropout ; Health disparities
• 刊名：Journal of Substance Abuse Treatment
• 出版年：2017
• 出版时间：March 2017
• 年：2017
• 卷：74
• 期：Complete
• 页码：65-70
• 全文大小：256 K
• 卷排序：74

文摘

Long-term (≥ 1 year) retention in office-based buprenorphine treatment is common. Significant disparities exist in buprenorphine treatment retention. Lower retention among Black, Hispanic, unemployed or hepatitis C positive patients Higher retention among patients who were female, older or had a psychiatric diagnosis